2023-03-30 05:23:32 ET
Summary
- Alignment Healthcare has a strong growth potential, particularly in the Medicare Advantage industry, and has shown remarkable growth.
- 4Q22 earnings exceeded expectations, with revenue of $362 million, 98,400 active members, and an MBR of 90.1%.
- ALHC to focus on its growth drivers, such as strengthening its connections with healthcare providers, improving its cost structure, and expanding its distribution strategy.
- I believe ALHC stock is undervalued at 0.5x forward revenue, despite the strong growth outlook and reaffirmation of EBITDA breakeven in FY24.
For further details see:
Alignment Healthcare: Good Risk/Reward Situation For Long-Term Holders